Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 83.12

-2.1%

Jan 30 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (3250)	5/8/2015 10:37:18 AM
From: Jibacoa	Read Replies (1) of 3722

ALDR was among a group of Biotechs that reported 1stQ results this week. It had no revenues for the Q vs.$4.8Ms in 2014 since BMY terminated its worldwide rights for clazakizumab, that returned to ALDR in Dec. <g> The loss for the Q was $14.7Ms vs. $5.4Ms, but on a per shr basis it was only $0.40Ms vs. $5.4 Ms, since ALDR has raised a good amount of Csh and as of Mar31, it had $230.3Ms in cash vs. $55.9Ms on Dec31<g> At any rate, the stock is up 17.46% on moderate volume of 97Ks, about 1/3 of its ADV. <g> The stock made an all time H as it traded above its Jan H. <g> bigcharts.marketwatch.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next